Literature DB >> 19828622

Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

David N Everly1, Bernardo A Mainou, Nancy Raab-Traub.   

Abstract

LMP1 induces the phenotypic transformation of fibroblasts and affects regulators of the cell cycle during this process. LMP1 decreases expression of the cyclin-dependent kinase inhibitor p27 and increases the levels and phosphorylation of cyclin-dependent kinase 2 and the retinoblastoma protein. In the present study, the effects of LMP1 on cell cycle progression and the mechanism of p27 downregulation by LMP1 were determined. Although p27 is frequently regulated at the posttranscriptional level during cell cycle progression and in cancer, LMP1 did not decrease ectopically expressed p27. However, LMP1 did decrease p27 RNA levels and inhibited the activity of p27 promoter reporters. The LMP1-regulated promoter element was mapped to a region containing two E2F sites. Electrophoretic mobility shift assays determined that the regulated cis element bound an inhibitory E2F complex containing E2F4 and p130. These findings indicate that LMP1 decreases p27 transcription through effects on E2F family transcription factors. This property likely contributes to the ability of LMP1 to stimulate cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828622      PMCID: PMC2786828          DOI: 10.1128/JVI.01422-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.

Authors:  R Iwanaga; H Komori; S Ishida; N Okamura; K Nakayama; K I Nakayama; K Ohtani
Journal:  Oncogene       Date:  2006-03-16       Impact factor: 9.867

2.  BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).

Authors:  E A Williamson; I Wolf; J O'Kelly; S Bose; S Tanosaki; H P Koeffler
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

3.  Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.

Authors:  Bernardo A Mainou; David N Everly; Nancy Raab-Traub
Journal:  Oncogene       Date:  2005-10-20       Impact factor: 9.867

4.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.

Authors:  Mark Gilchrist; Vesteinn Thorsson; Bin Li; Alistair G Rust; Martin Korb; Jared C Roach; Kathleen Kennedy; Tsonwin Hai; Hamid Bolouri; Alan Aderem
Journal:  Nature       Date:  2006-05-11       Impact factor: 49.962

6.  LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.

Authors:  N J Thornburg; W Kulwichit; R H Edwards; K H Y Shair; K M Bendt; N Raab-Traub
Journal:  Oncogene       Date:  2006-01-12       Impact factor: 9.867

Review 7.  Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.

Authors:  Elza Ibrahim Auerkari
Journal:  Oral Oncol       Date:  2005-06-22       Impact factor: 5.337

Review 8.  Mouse models of cell cycle regulators: new paradigms.

Authors:  Eiman Aleem; Philipp Kaldis
Journal:  Results Probl Cell Differ       Date:  2006

9.  Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.

Authors:  Jason S Knight; Nikhil Sharma; Erle S Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

10.  In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.

Authors:  Catherine Pioche-Durieu; Cécile Keryer; Sylvie Souquère; Jacques Bosq; Wolfgang Faigle; Damarys Loew; Mitsuomi Hirashima; Nozomu Nishi; Jaap Middeldorp; Pierre Busson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

View more
  8 in total

1.  Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins.

Authors:  Kirsten Holthusen; Pooja Talaty; David N Everly
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

2.  The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Authors:  Mark A Rider; Mujeeb R Cheerathodi; Stephanie N Hurwitz; Dingani Nkosi; Lauren A Howell; Deanna C Tremblay; Xia Liu; Fanxiu Zhu; David G Meckes
Journal:  Virology       Date:  2018-01-09       Impact factor: 3.616

3.  Epstein-Barr virus infection is inversely correlated with the expression of retinoblastoma protein in Reed-Sternberg cells in classic Hodgkin lymphoma.

Authors:  Suhail Al-Salam; Aktham Awwad; Mouied Alashari
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

4.  Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.

Authors:  Yonggang Pei; Josiah Hiu-Yuen Wong; Hem Chandra Jha; Tian Tian; Zhi Wei; Erle S Robertson
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

5.  Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagen.

Authors:  Pooja Talaty; Amanda Emery; Kirsten Holthusen; David N Everly
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

6.  Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation.

Authors:  Pooja Talaty; Amanda Emery; David N Everly
Journal:  Virol J       Date:  2011-08-24       Impact factor: 4.099

7.  14-3-3ζ coordinates adipogenesis of visceral fat.

Authors:  Gareth E Lim; Tobias Albrecht; Micah Piske; Karnjit Sarai; Jason T C Lee; Hayley S Ramshaw; Sunita Sinha; Mark A Guthridge; Amparo Acker-Palmer; Angel F Lopez; Susanne M Clee; Corey Nislow; James D Johnson
Journal:  Nat Commun       Date:  2015-07-29       Impact factor: 14.919

8.  EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.

Authors:  Yonggang Pei; Shuvomoy Banerjee; Zhiguo Sun; Hem Chandra Jha; Abhik Saha; Erle S Robertson
Journal:  PLoS Pathog       Date:  2016-08-22       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.